Diagnostic dilemma in COVID-19-associated pulmonary aspergillosis - Authors' reply

Affiliations

¹ Department I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), University Hospital Cologne, 50937 Cologne, Germany; Faculty of Medicine and Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases, University of Cologne, Cologne, Germany.
² Mycology Reference Laboratory, Public Health Wales Microbiology Cardiff, Cardiff, UK.
³ Department of Medical Microbiology, ECMM, Center of Expertise in Mycology Radboudumc/CWZ, Nijmegen, Netherlands; Center for Infectious Diseases Research, Diagnostics and Laboratory Surveillance, National Institute for Public Health and the Environment, Bilthoven, Netherlands.
⁴ Department I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), University Hospital Cologne, 50937 Cologne, Germany; Faculty of Medicine and Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases, University of Cologne, Cologne, Germany; Clinical Trials Centre Cologne, ZKS Köln, Cologne, Germany; German Center for Infection Research, Partner Site Bonn-Cologne, Cologne, Germany. Electronic address: oliver.cornely@uk-koeln.de.

Comment

Philipp Koehler et al. Lancet Infect Dis. 2021 Jun.

. 2021 Jun;21(6):767-769.

doi: 10.1016/S1473-3099(21)00123-7. Epub 2021 Mar 1.

¹ Department I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), University Hospital Cologne, 50937 Cologne, Germany; Faculty of Medicine and Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases, University of Cologne, Cologne, Germany.
² Mycology Reference Laboratory, Public Health Wales Microbiology Cardiff, Cardiff, UK.
³ Department of Medical Microbiology, ECMM, Center of Expertise in Mycology Radboudumc/CWZ, Nijmegen, Netherlands; Center for Infectious Diseases Research, Diagnostics and Laboratory Surveillance, National Institute for Public Health and the Environment, Bilthoven, Netherlands.
⁴ Department I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), University Hospital Cologne, 50937 Cologne, Germany; Faculty of Medicine and Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases, University of Cologne, Cologne, Germany; Clinical Trials Centre Cologne, ZKS Köln, Cologne, Germany; German Center for Infection Research, Partner Site Bonn-Cologne, Cologne, Germany. Electronic address: oliver.cornely@uk-koeln.de.

No abstract available

Comment on

Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance.
Koehler P, Bassetti M, Chakrabarti A, Chen SCA, Colombo AL, Hoenigl M, Klimko N, Lass-Flörl C, Oladele RO, Vinh DC, Zhu LP, Böll B, Brüggemann R, Gangneux JP, Perfect JR, Patterson TF, Persigehl T, Meis JF, Ostrosky-Zeichner L, White PL, Verweij PE, Cornely OA; European Confederation of Medical Mycology; International Society for Human Animal Mycology; Asia Fungal Working Group; INFOCUS LATAM/ISHAM Working Group; ISHAM Pan Africa Mycology Working Group; European Society for Clinical Microbiology; Infectious Diseases Fungal Infection Study Group; ESCMID Study Group for Infections in Critically Ill Patients; Interregional Association of Clinical Microbiology and Antimicrobial Chemotherapy; Medical Mycology Society of Nigeria; Medical Mycology Society of China Medicine Education Association; Infectious Diseases Working Party of the German Society for Haematology and Medical Oncology; Association of Medical Microbiology; Infectious Disease Canada. Koehler P, et al. Lancet Infect Dis. 2021 Jun;21(6):e149-e162. doi: 10.1016/S1473-3099(20)30847-1. Epub 2020 Dec 14. Lancet Infect Dis. 2021. PMID: 33333012 Free PMC article. Review.

1. Koehler P, Bassetti M, Chakrabarti A, et al. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis. 2020 doi: 10.1016/S1473-3099(20)30847-1. published online Dec 14. - DOI - PMC - PubMed
1. Salmanton-García J, Sprute R, Stemler J, et al. COVID-19–associated pulmonary aspergillosis, March–August 2020. Emerg Infect Dis. 2021 doi: 10.3201/eid2704.204895. published online Feb 4. - DOI - PMC - PubMed
1. WHO Working Group on the Clinical Characterisation and Management of COVID-19 infection A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect Dis. 2020;20:e192–e197. - PMC - PubMed
1. Koehler P, Cornely OA, Kochanek M. Bronchoscopy safety precautions for diagnosing COVID-19 associated pulmonary aspergillosis—a simulation study. Mycoses. 2021;64:55–59. - PubMed
1. Gao CA, Bailey JI, Walter JM, et al. Bronchoscopy on intubated COVID-19 patients is associated with low infectious risk to operators. Ann Am Thorac Soc. 2021 doi: 10.1513/annalsats.202009-1225rl. published online Jan 15. - DOI - PMC - PubMed